Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    23099329 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Study to Assess the Effect of Adjuvant and Route of Administration on the Safety, Tolerability, and Immunogenicity of NDV-3 Vaccine Against S.Aureus and Candida
Conditions: Staphylococcal Infections;   Yeast Infections;   Candidiasis
Interventions: Biological: NDV-3 vaccine with alum administered IM;   Biological: NDV-3 vaccine without alum administered IM;   Biological: Placebo administered ID;   Biological: NDV-3 vaccine without alum administered ID

Indicates status has not been verified in more than two years